Jubilant Pharmova Ltd (JUBLPHARMA) is currently trading at 948.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Jubilant Pharmova is a globally integrated pharmaceutical company specializing in radiopharmaceuticals, contract research, and proprietary novel drugs. With a strategic focus on specialty products, its reach spans across geographies from North America to Asia. Key growth drivers include its radiopharmaceutical capabilities, particularly in the U.S., where it holds substantial market share. The company's innovative pursuits are underscored by ongoing clinical trials in precision medicines targeting oncology, with strategic partnerships bolstering its R&D efforts.

Over the past 52 weeks, Jubilant Pharmova Ltd has traded between a low of ₹823.70 and a high of ₹1,250.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Jubilant Pharmova Ltd has a market capitalization of approximately 15,137.48. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Jubilant Pharmova Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 30.46 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Jubilant Pharmova Ltd (JUBLPHARMA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 15,137.48 Cr, Jubilant Pharmova Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Jubilant Pharmova Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Jubilant Pharmova Ltd is 30.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Jubilant Pharmova Ltd pays dividends with a current dividend yield of 0.53%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Jubilant Pharmova Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.